Baxter Aims At Biosimilar Enbrel Market in Deal with Coherus
Baxter and Coherus Biosciences have become the latest firms to try and develop a biosimilar version of the RA treatment Enbrel in a new collaboration announced this week.
Archives for September 3, 2013
Bioreliance Launches Updated Big Blue Mouse Assay Service
Bioreliance has launched an updated version of its mutagenicity service after conducting studies that confirmed its Big Blue Mouse assay still meets OECD standards.
Sanofi Buys Freeslate’s Biologics Formulation System
Sanofi Pasteur has purchased Freeslate’s biologics formulation system to accelerate its vaccine research and protein development programmes.
Vela and Evercyte to Develop Immortal Cells for Biosimilars Testing
Vela Laboratories has teamed up with Evercyte to develop and commercialize cell lines for the assessment of biosimilars.